Skip to Main Content

Author Details

Taher Abbasi
Cellworks Group Inc.
2011
33
17
PMIDPaper TitleJournal TitlePublished Year
34994595Computational Biological Modeling Identifies PD-(L)1 Immunotherapy Sensitivity Among Molecular Subgroups of <i>KRAS</i>-Mutated Non-Small-Cell Lung Cancer.JCO Precis Oncol2021
32417407Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide.Int J Radiat Oncol Biol Phys2020
30641417Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomics.Leuk Res2019
31350446Computational Models Accurately Predict Multi-Cell Biomarker Profiles in Inflammation and Cancer.Sci Rep2019
31208955A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients.Blood Adv2019
31009835Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis.Leuk Res2019
31103719A feedforward relationship between active Rac1 and phosphorylated Bcl-2 is critical for sustaining Bcl-2 phosphorylation and promoting cancer progression.Cancer Lett2019
30642575Predicting response to BET inhibitors using computational modeling: A BEAT AML project study.Leuk Res2019
29175379Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study.Leuk Res2018
29543996Human beta defensin 3 alters matrix metalloproteinase production in human dendritic cells exposed to Porphyromonas gingivalis hemagglutinin B.J Periodontol2018
29486723Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.BMC Cancer2018
29649990Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.BMC Cancer2018
27855285Computational drug treatment simulations on projections of dysregulated protein networks derived from the myelodysplastic mutanome match clinical response in patients.Leuk Res2017
28756882Cell genomics and immunosuppressive biomarker expression influence PD-L1 immunotherapy treatment responses in HNSCC-a computational study.Oral Surg Oral Med Oral Pathol Oral Radiol2017
27056884Identification of myeloproliferative neoplasm drug agents via predictive simulation modeling: assessing responsiveness with micro-environment derived cytokines.Oncotarget2016
28239565PD-L1 is a diverse molecule regulating both tumor-intrinsic signaling and adaptive immunosuppression.Transl Cancer Res2016
26650066AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models.J Neurooncol2016
27688163Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation models.Cancer Immunol Immunother2016
25638213Personalization of cancer treatment using predictive simulation.J Transl Med2015
26430964Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide.Oncotarget2015
23765383β-Caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase.Mol Carcinog2014
25093497In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells.Br J Cancer2014
24847381Predictive simulation approach for designing cancer therapeutic regimens with novel biological mechanisms.J Cancer2014
24884660In silico modeling predicts drug sensitivity of patient-derived cancer cells.J Transl Med2014
24405121PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance.Br J Haematol2014
23671273Elastin sequences trigger transient proinflammatory responses by human dermal fibroblasts.FASEB J2013
24124799Oral inflammation, a role for antimicrobial peptide modulation of cytokine and chemokine responses.Expert Rev Anti Infect Ther2013
23848338Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3.Br J Pharmacol2013
21792937Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.J Cell Physiol2012
22992727Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer.J Biol Chem2012
21131551Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo.Clin Cancer Res2011
21506956Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells.Br J Pharmacol2011
21465181Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.J Mol Med (Berl)2011
  • 1 - 33 of 33

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 1
Brian J Capaldo
Center for Cancer Research, National Cancer Institute
Career Start Year 2012
Number of shared co-authors 0
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2011
Number of shared co-authors 11
Jin-Ku Lee
Seoul National University, College of Medicine
Career Start Year 2010
Number of shared co-authors 0
Huiyuan Zhang
Texas Children's Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Shweta Joshi
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 1
Kris C Wood
Duke University
Career Start Year 2005
Number of shared co-authors 0
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 4
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
Habib Hamidi
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 1
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Andrey Loboda
Merck & Co., Inc.
Career Start Year 1998
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 0
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 4
Ricky W Johnstone
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 6
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Shireen Vali
Cellworks Group Inc.
Co-authored papers 31
Leylah M Drusbosky
College of Medicine, University of Florida
Co-authored papers 6
Christopher R Cogle
College of Medicine, University of Florida
Co-authored papers 6
Anay Talawdekar
Cellworks Research India Pvt Ltd
Co-authored papers 5
Ashish Agrawal
Cellworks Research India Pvt. Ltd
Co-authored papers 3
Robinson Vidva
Cellworks Research India Pvt. Ltd
Co-authored papers 2
Kimberly E Hawkins
College of Medicine, University of Florida
Co-authored papers 2
Ravi Vij
Co-authored papers 2
Timothy A Chan
Cleveland Clinic.
Co-authored papers 2
Terry A Braun
University of Iowa
Co-authored papers 2
Claes Wahlestedt
Co-authored papers 1
Brian J Druker
Oregon Health & Science University
Co-authored papers 1
Erliang Zeng
College of Dentistry, University of Iowa
Co-authored papers 1
Bijal Shah
Moffitt Cancer Center
Co-authored papers 1
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Amanda Winters
University of Colorado School of Medicine
Co-authored papers 1
Diana Abbott
Center for Innovative Design and Analysis, University of Colorado, Aurora CO.
Co-authored papers 1
Jonathan C Trent
Sylvester Comprehensive Cancer Center, University of Miami
Co-authored papers 1
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 1
Ronan Swords
Oregon Health and Science University
Co-authored papers 1
Francisco Vega
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Chandan Kumar-Sinha
Co-authored papers 1
Veronica Clavijo Jordan
Harvard Medical School
Co-authored papers 1
Vijayashree P Shyamasundar
Cellworks Research India Pvt. Ltd
Co-authored papers 1
Parag Mallick
Stanford University
Co-authored papers 1
Saji Gera
Cellworks Research India Pvt. Ltd
Co-authored papers 1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Dayu Teng
Co-authored papers 1
Anjanasree V Lakshminarayana
Cellworks Research India Pvt. Ltd
Co-authored papers 1
Brett M Stevens
University of Colorado School of Medicine
Co-authored papers 1
Release 1.2